Replies to post #388898 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

First SequestOx wasn’t a great product, the CEO knew it and had to submit a 2.0 version. Had FDA gone route of forcing non-ADT off the market, which is where they were leaning, Elite would have been the leader among the opioid space on getting a significant market share vs 5-10%.

Please note that Adderall ER has a total market of like $1.5B and yet where do Elite’s Adderall XR sales sit today? Less than 1% of the total market. Burel is going to open doors here, but Elite barely scratched the surface. Let’s be cognizant of total market capture as total market means nothing if you can’t sell your way out of a paper bag (Lannett).